Regulatory
HIPAA now expects risk analysis with teeth
The Security Rule, HHS 405(d) and HICP all point to risk-based, documented vulnerability management. Unexploitable CVSS 9s are not the risk.
Industry
Hospital systems run thousands of connected devices that cannot be patched on the vendor's schedule, next to EHR platforms that cannot go down. Zafran shows which exposures are reachable and exploitable, and closes them with the controls already on the network.
Pressures
Regulatory
The Security Rule, HHS 405(d) and HICP all point to risk-based, documented vulnerability management. Unexploitable CVSS 9s are not the risk.
Attack surface
Infusion pumps, imaging and lab systems run vendor-controlled firmware. Compensating controls are the only realistic path for most of them.
Operational reality
A handful of security staff cover many hospitals. Every ticket sent to clinical engineering has to be one that matters.
Regulations & frameworks
Zafran's validation record shows which exposures were exploitable, which were mitigated by a control, and when. That is the artifact these frameworks want.
How Zafran helps
01 · Continuous Discovery & Detection
Agentless discovery finds clinical and IoMT devices that scanners miss and correlates them with existing inventory and scanner data.
03 · Risk Mitigation
Map each exposure to the segmentation, NAC, IPS or EDR control that already blocks it, and close the gaps where coverage is missing.
04 · Remediation Workflows
Group findings by root cause and device fleet, route to the right owner and track to closure in your ITSM.
Proof
Major Healthcare System
Validated which criticals were exploitable and mitigated the rest through existing controls, without waiting on device vendors.
Health Sisters Hospital System
Consolidated visibility across facilities and prioritized by what was reachable on the clinical network.
Trusted in healthcare
Threat intel
A home for vertical-specific research as it is produced. Placeholders only in this wireframe.
Quarterly
Exposure trends, actively exploited CVEs and control gaps observed across healthcare environments.
Weekly
Newly weaponized vulnerabilities this week, which of them are reachable in this vertical, and the fastest mitigation path.
FAQ
It produces a documented, risk-based view of which vulnerabilities are exploitable on systems handling ePHI and which controls mitigate them, the analysis the Security Rule asks for.
Yes. Zafran maps each device exposure to the network and endpoint controls already in place and shows where a compensating control closes the path.
No. Discovery is agentless and works from network, inventory and scanner data.
Findings are grouped by device fleet and root cause and routed as a small number of actionable tickets, with mitigation status visible to both teams.
Both recommend prioritized, documented vulnerability management with compensating controls for legacy systems. Zafran operationalizes that recommendation.
Bring your scanner exports and control stack; we will show what is actually exploitable and what your existing tools can already stop.